CII
Capital International Inc Portfolio holdings
AUM
$10.3B
1-Year Return
33.09%
This Quarter Return
-6.15%
1 Year Return
+33.09%
3 Year Return
+130.02%
5 Year Return
+217.83%
10 Year Return
+680.45%
AUM
$8.92B
AUM Growth
-$1.83B
(-17%)
Cap. Flow
-$706M
Cap. Flow
% of AUM
-7.91%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
318
New
16
Increased
69
Reduced
201
Closed
23
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$53.9M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$48.9M |
| 3 |
Wolfspeed
WOLF
|
+$42.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$40.3M |
| 5 |
Pfizer
PFE
|
+$39.6M |
Top Sells
| 1 |
Tesla
TSLA
|
+$88.7M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$68.1M |
| 3 |
Amazon
AMZN
|
+$51.2M |
| 4 |
L3Harris
LHX
|
+$49.8M |
| 5 |
Church & Dwight Co
CHD
|
+$44.7M |
Sector Composition
| 1 | Technology | 23.3% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Financials | 13.11% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
IDEX
IEX
$12.3B
| $711K | 0.01% |
3,710
-31,363
| -89% | -$6.01M |
|
277
Webster Financial
WBS
$10.2B
| $600K | 0.01% |
10,686
-1,312
| -11% | -$73.7K |
|
278
Air Products & Chemicals
APD
$66.1B
| $587K | 0.01% |
2,347
-7,622
| -76% | -$1.91M |
|
279
Merck
MRK
$210B
| $555K | 0.01% |
6,763
-4,812
| -42% | -$395K |
|
280
Paychex
PAYX
$48.7B
| $516K | 0.01% |
3,780
-4,641
| -55% | -$634K |
|
281
Dow Inc
DOW
$17.8B
| $495K | 0.01% |
7,772
-105,277
| -93% | -$6.71M |
|
282
Humana
HUM
$33.6B
| $460K | 0.01% |
1,057
-83
| -7% | -$36.1K |
|
283
State Street
STT
$32.1B
| $411K | ﹤0.01% |
4,713
-41
| -0.9% | -$3.58K |
|
|
FTCH
284
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $407K | ﹤0.01% |
26,933
-9,646
| -26% | -$146K |
|
285
Grupo Aeroportuario del Pacifico
PAC
$13B
| $401K | ﹤0.01% |
2,485
-2,780
| -53% | -$449K |
|
286
Evergy
EVRG
$16.6B
| $317K | ﹤0.01% |
+4,639
| New | +$317K |
|
287
Jack Henry & Associates
JKHY
$11.7B
| $299K | ﹤0.01% |
1,516
-19
| -1% | -$3.75K |
|
288
AB InBev
BUD
$115B
| $290K | ﹤0.01% |
4,829
-732
| -13% | -$44K |
|
289
Exelon
EXC
$44B
| $282K | ﹤0.01% |
5,914
-2,882
| -33% | -$137K |
|
290
Novo Nordisk
NVO
$243B
| $242K | ﹤0.01% |
4,360
-538
| -11% | -$29.9K |
|
291
Constellation Energy
CEG
$99.9B
| $228K | ﹤0.01% |
+4,053
| New | +$228K |
|
292
Arthur J. Gallagher & Co
AJG
$76.8B
| $225K | ﹤0.01% |
1,288
-150
| -10% | -$26.2K |
|
293
Viatris
VTRS
$11.8B
| $133K | ﹤0.01% |
12,199
-6,656
| -35% | -$72.6K |
|
294
Amgen
AMGN
$151B
| – | – |
-5,420
| Closed | -$1.22M |
|
295
Aptiv
APTV
$18.3B
| – | – |
-17,481
| Closed | -$2.88M |
|
296
BioNTech
BNTX
$24.3B
| – | – |
-14,036
| Closed | -$3.62M |
|
|
297
Church & Dwight Co
CHD
$22.9B
| – | – |
-436,286
| Closed | -$44.7M |
|
298
Galapagos
GLPG
$2.12B
| – | – |
-10,653
| Closed | -$587K |
|
299
AbCellera Biologics
ABCL
$1.37B
| – | – |
-929,578
| Closed | -$13.3M |
|
300
Advanced Micro Devices
AMD
$253B
| – | – |
-103,589
| Closed | -$14.9M |
|